Skip to main content
. 2000 Dec 4;192(11):1653–1660. doi: 10.1084/jem.192.11.1653

Figure 4.

Figure 4

Sequential effect of anti-RESA and anti-MSP3b Abs. Course of parasitemia in two P.f.-HuRBC-BXN mice receiving sequential treatment first by HuMNs, then by HuMNs together with anti-RESA peptide Abs (250 μl of a solution with a titer of 1:2,000 by IFA), and followed by HuMNs together with anti-MSP3b peptide Abs (250 μl, IFA 1:200). The arrows show the days at which treatment was administered. −, absence of residual parasites in thin blood smears.